MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$1,768M
Free Cash flow
$5,654M
Unit: Million (M) dollars
Positive Cash Flow Breakdown
Net income
Accounts receivable, net
Proceeds from sales and maturiti...
Others
Negative Cash Flow Breakdown
Accounts payable and pharmacy cl...
Purchases of investments
Other liabilities
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Proceeds from sales and maturities of investments
3,324
-
-
2,774
Purchases of investments
4,518
-
-
3,859
Purchases of property and equipment
691
-
-
698
Acquisitions
4
-
-
290
Other
-5
-
-
14
Net cash used in investing activities
-1,884
-
-
-2,087
Commercial paper borrowings (repayments), net
0
-
-
-1,793
Proceeds from issuance of long-term debt
-
-
-
3,969
Repayments of long-term debt
1,769
-
-
2,847
Repurchase of common stock
-
-
-
0
Dividends paid
878
-
-
846
Proceeds from exercise of stock options
114
-
-
117
Payments for taxes related to net share settlement of equity awards
145
-
-
20
Other
-15
-
-
38
Net cash used in financing activities
-2,693
-
-
-1,382
Net income
7,147
-
-
-3,990
Stock-based compensation
42
-
-
138
Loss on sale of subsidiary
236
-
-
0
Restructuring charges (impairment of long-lived assets)
-
-
-
0
Deferred income taxes and other items
199
-
-
-157
Accounts receivable, net
-7,004
-
-
3,398
Inventories
-2,606
-
-
1,653
Other assets
-1,943
-
-
-381
Accounts payable and pharmacy claims and discounts payable
-5,396
-
-
1,221
Health care costs payable and other insurance liabilities
-69
-
-
768
Other liabilities
-3,435
-
-
1,110
Goodwill impairment
-
-
-
5,725
Gain on deconsolidation of subsidiary
-
-
-
483
Depreciation and amortization
-1,218
-
-
1,134
Net cash provided by operating activities
6,345
-
-
796
Net increase in cash, cash equivalents and restricted cash
1,768
-
-
-2,673
Goodwill impairment
-
-
-
5,725
Gain on deconsolidation of subsidiary
-
-
-
483
Net income
7,147
-
-
-3,990
Cash receipts from customers
104,267
94,201
105,750
96,878
Cash paid for inventory, prescriptions dispensed and health services rendered
57,038
50,551
58,644
56,651
Insurance benefits paid
30,005
28,398
32,469
29,925
Cash paid to other suppliers and employees
10,540
10,775
10,262
8,678
Interest and investment income received
495
526
475
522
Interest paid
460
1,091
462
1,045
Income taxes paid
374
-337
998
305
Net cash provided by operating activities
6,345
4,249
3,390
796
Proceeds from sales and maturities of investments
3,324
4,159
2,743
2,774
Purchases of investments
4,518
4,186
3,967
3,859
Purchases of property and equipment
691
849
784
698
Acquisitions
4
5
7
290
Other
-5
-7
-17
14
Net cash used in investing activities
-1,884
-874
-1,998
-2,087
Commercial paper borrowings (repayments), net
0
0
-1,247
-1,793
Proceeds from issuance of short-term loan
-
-
0
-
Repayment of short-term loan
-
-
0
-
Proceeds from issuance of long-term debt
-
-
0
3,969
Repayments of long-term debt
1,769
1,518
20
2,847
Repurchase of common stock
-
-
0
0
Dividends paid
878
847
845
846
Proceeds from exercise of stock options
114
103
86
117
Payments for taxes related to net share settlement of equity awards
145
9
13
20
Other
-15
-47
7
38
Net cash used in financing activities
-2,693
-2,318
-2,032
-1,382
Net increase in cash, cash equivalents and restricted cash
1,768
1,057
-640
-2,673
Cash, cash equivalents and restricted cash at the beginning of the period
9,769
8,712
10,346
10,346
Cash, cash equivalents and restricted cash at the end of the period
11,537
9,769
8,712
9,352
Page 1
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income
$7,147M
(605.53%↑ Y/Y)
Accounts receivable, net
-$7,004M
(-744.94%↓ Y/Y)
Inventories
-$2,606M
(-5209.80%↓ Y/Y)
Other assets
-$1,943M
(-1371.97%↓ Y/Y)
Deferred income taxes and
other items
$199M
(274.56%↑ Y/Y)
Stock-based compensation
$42M
(-69.12%↓ Y/Y)
Net cash provided by
operating activities
$6,345M
(234.48%↑ Y/Y)
Canceled cashflow
$12,596M
Net increase in
cash, cash...
$1,768M
(5.30%↑ Y/Y)
Canceled cashflow
$4,577M
Accounts payable and
pharmacy claims and...
-$5,396M
(-545.21%↓ Y/Y)
Other liabilities
-$3,435M
(-2811.02%↓ Y/Y)
something is missing
-$2,242M
Depreciation and
amortization
-$1,218M
(-204.01%↓ Y/Y)
Loss on sale of
subsidiary
$236M
Health care costs
payable and other...
-$69M
(82.66%↑ Y/Y)
Proceeds from exercise of
stock options
$114M
(142.55%↑ Y/Y)
Proceeds from sales and
maturities of investments
$3,324M
(-0.24%↓ Y/Y)
Other
-$5M
(-25.00%↓ Y/Y)
Net cash used in
financing activities
-$2,693M
(-434.12%↓ Y/Y)
Net cash used in
investing activities
-$1,884M
(-83.98%↓ Y/Y)
Canceled cashflow
$114M
Canceled cashflow
$3,329M
Repayments of long-term
debt
$1,769M
(9210.53%↑ Y/Y)
Dividends paid
$878M
(1.39%↑ Y/Y)
Payments for taxes
related to net share...
$145M
(27.19%↑ Y/Y)
Purchases of investments
$4,518M
(24.33%↑ Y/Y)
Other
-$15M
(31.82%↑ Y/Y)
Purchases of property and
equipment
$691M
(13.84%↑ Y/Y)
Acquisitions
$4M
(-96.64%↓ Y/Y)
Buy us a coffee
CVS_Health_Logo-svg
CVS HEALTH Corp (CVS)
CVS_Health_Logo-svg
CVS HEALTH Corp (CVS)
Show more